Wolters Kluwer Health has launched a new “Advanced Compounding” module for its compliance software Simplifi 797, offering pharmacies a comprehensive solution to meet the updated requirements of USP Chapter 797.
The module is designed to support even the most complex compounding operations — from high-risk sterile processes to non-sterile-to-sterile transformations and extended shelf-life (beyond-use dating) medications.
It provides a closed-loop system that integrates compliance workflows, documentation, environmental-monitoring records, staff competency tracking, and audit-ready reporting. Pharmacies can use it to capture required batch-level data, record environmental conditions, maintain training and competency logs, and generate inspection-ready reports — replacing fragmented paper-based processes.
With educational content, procedural templates, and structured workflows developed by Wolters Kluwer’s experts, the Advanced Compounding module helps standardise compounding practices and ensures pharmacies stay aligned with regulatory standards.
By supporting the full spectrum of compounding — from immediate-use preparations to the highest-risk Category 3 sterile compounding — Simplifi 797 with the new module positions itself as a turnkey compliance solution for hospitals, specialty pharmacies, oncology clinics, home-infusion centres, and other compounding facilities.
